arrow
H

Harald E. Vonkeman

Maastricht University
H指数:38
被引数:6,174

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Plasma metabolomics reveals candidate biomarkers associated with individual treatment response in psoriatic arthritis

血浆代谢组学揭示与银屑病关节炎个体治疗反应相关的候选生物标志物

2026-10-090
OAAI
Disentangling patient, disease, and treatment effects: proteomic and metabolomic differences in early versus established psoriatic arthritis

解析患者、疾病和治疗效应:早期与已确诊银屑病关节炎的蛋白质组学和代谢组学差异

2026-01-011
PRE
Almost half of the patients with axial spondyloarthritis reporting an acceptable symptom state have high disease activity; data from two standard-of-care cohorts

轴性脊柱关节炎患者中,将近一半报告症状可接受状态的患者疾病活动度较高;来自两个标准护理队列的数据

2025-12-290
OAAI
PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA) trial: a multicentre, open-label, randomised controlled trial comparing routine care with a tailor-made approach

PRIMERA试验:一项多中心、开放标签、随机对照试验,比较常规护理与定制化方法

2025-12-010
OA
STRUCTURAL AND- INFLAMMATORY IMAGING PARAMETERS IN PSORIATIC ARTHRITIS: A COMPARISON OF DMARD-NAIVE AND DMARDFAILURE PATIENTS

银屑病关节炎的结构和炎症成像参数:DMARD-naive患者与DMARD-failure患者的比较

2024-06-010
PRE
THE DEVELOPMENT OF A CLINICAL PREDICTION MODEL FOR TREATMENT RESPONSE IN INDIVIDUAL PSORIATIC ARTHRITIS PATIENTS

个体银屑病关节炎患者治疗反应的临床预测模型开发

2024-06-011
PRE
PROTEOMIC DIFFERENCES BETWEEN TREATMENT NAÏVE AND ESTABLISHED ACTIVE PSORIATIC ARTHRITIS PATIENTS: DISENTANGLING PATIENT, DISEASE AND TREATMENT EFFECTS

治疗未接受过治疗的患者与已确诊活动性银屑病关节炎患者之间的蛋白质组学差异:区分患者、疾病和治疗效应

2024-06-010
PRE